MYCIFRADIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mycifradin, and what generic alternatives are available?
Mycifradin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in MYCIFRADIN is neomycin sulfate. There are nineteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mycifradin
A generic version of MYCIFRADIN was approved as neomycin sulfate by XGEN PHARMS on July 28th, 2006.
Summary for MYCIFRADIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Clinical Trials: | 2 |
Patent Applications: | 4,296 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYCIFRADIN at DailyMed |
Recent Clinical Trials for MYCIFRADIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Emory University | Phase 4 |
Valeant Pharmaceuticals International, Inc. | N/A |
Bausch Health Americas, Inc. | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for MYCIFRADIN
US Patents and Regulatory Information for MYCIFRADIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | MYCIFRADIN | neomycin sulfate | SOLUTION;ORAL | 050285-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | MYCIFRADIN | neomycin sulfate | TABLET;ORAL | 060520-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |